MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
ALEC — Alector, Inc. Common Stock
NasdaqAlector, Inc. Common Stock
$1.86
+0.01(+0.54%)
- O
- 1.82
- H
- 1.91
- L
- 1.81
- V
- 774.39K
⏱️ End-of-day dataAs of Oct 1, 2026
Chart
About ALEC
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
SectorNot available
IPO DateFeb 7, 2019
Employees103
Stock ExchangeNasdaq
Ticker SymbolALEC
Websitehttps://www.alector.com
Key Financial Statistics
| Market Cap | $217.73M |
| P/E Ratio | N/A |
| Dividend Yield | N/A |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.87 - $43.32 |
| 52-Week Avg Volume | 775.7K |
| VWAP | $1.87 |
| Transactions | 5,127 |
| Total Recorded Bars | 1,923 days |